Table X.
Gene | SNP | Hypertension | DM | Hyper-TG | Hypo-HDL | Hyper-LDL | CKD | Obesity | Hyperuricemia | |
---|---|---|---|---|---|---|---|---|---|---|
PLCB2 | rs200787930 | C/T | 0.0004 | 0.0026 | 0.5013 | <0.0001 | <0.0001 | <0.0001 | 0.0482 | 0.7764 |
CXCL8 | rs188378669 | G/T | 0.0007 | 0.0039 | 0.8922 | <0.0001 | <0.0001 | <0.0001 | 0.0259 | 0.9412 |
MARCH1 | rs61734696 | G/T | 0.0002 | 0.0013 | 0.5876 | <0.0001 | <0.0001 | <0.0001 | 0.0381 | 0.7835 |
VPS33B | rs199921354 | C/T | 0.0006 | 0.0026 | 0.5939 | <0.0001 | <0.0001 | <0.0001 | 0.0398 | 0.9038 |
TMOD4 | rs115287176 | G/A | 0.0006 | 0.0073 | 0.9087 | <0.0001 | <0.0001 | <0.0001 | 0.0578 | 0.8457 |
COL6A3 | rs146092501 C | /T | 0.0004 | 0.0058 | 0.8385 | <0.0001 | <0.0001 | <0.0001 | 0.0459 | 0.8305 |
ZNF77 | rs146879198 | G/A | 0.0014 | 0.0053 | 0.8625 | <0.0001 | <0.0001 | <0.0001 | 0.0245 | 0.9643 |
ADGRL3 | rs192210727 | G/T | 0.0106 | 0.0262 | 0.6918 | <0.0001 | <0.0001 | <0.0001 | 0.0501 | 0.5669 |
ALDH2 | rs671 | G/A | 0.0017 | 0.0231 | 0.0253 | <0.0001 | 0.0002 | 0.0297 | 0.0479 | <0.0001 |
ACAD10 | rs11066015 | G/A | 0.0014 | 0.0300 | 0.0261 | <0.0001 | 0.0002 | 0.0376 | 0.0578 | <0.0001 |
BRAP | rs3782886 | A/G | 0.0012 | 0.0675 | 0.0233 | <0.0001 | 0.0008 | 0.0329 | 0.0548 | <0.0001 |
HECTD4 | rs11066280 | T/A | 0.0052 | 0.2161 | 0.0093 | <0.0001 | 0.0002 | 0.0172 | 0.1293 | <0.0001 |
HECTD4 | rs2074356 | C/T | 0.0245 | 0.2148 | 0.0042 | <0.0001 | 0.0003 | 0.0218 | 0.2238 | <0.0001 |
OR52E4 | rs11823828 | T/G | 0.0429 | <0.0001 | 0.0917 | 0.2341 | 0.8312 | 0.0161 | 0.0768 | 0.1053 |
rs12229654 | T/G | 0.0200 | 0.4309 | 0.0996 | <0.0001 | 0.0290 | 0.0633 | 0.2134 | <0.0001 | |
NAA25 | rs12231744 | C/T | 0.0913 | 0.5214 | 0.0151 | 0.0002 | 0.2175 | 0.8586 | 0.3543 | 0.0055 |
ATXN2 | rs7969300 | T/C | 0.0368 | 0.6341 | 0.0001 | 0.0005 | 0.7189 | 0.3631 | 0.3155 | 0.0047 |
GOSR2 | rs1052586 | T/C | 0.5175 | 0.0843 | 0.3162 | 0.0718 | 0.1779 | 0.6525 | 0.4307 | 0.5766 |
TCHP | rs74416240 | G/A | 0.4244 | 0.0279 | 0.0630 | 0.0594 | 0.0142 | 0.0037 | 0.3409 | 0.1148 |
GIT2 | rs925368 | A/G | 0.3492 | 0.0515 | 0.0337 | 0.0873 | 0.0105 | 0.0020 | 0.4399 | 0.0998 |
rs2523644 | A/G | 0.4464 | 0.2581 | 0.5651 | 0.0797 | 0.0674 | 0.0397 | 0.4203 | 0.3215 | |
OAS3 | rs2072134 | C/T | 0.6477 | 0.0936 | 0.1902 | 0.0004 | 0.0030 | 0.1862 | 0.2580 | 0.0185 |
CCDC63 | rs10774610 | T/C | 0.3573 | 0.2133 | 0.2623 | 0.0030 | 0.0102 | 0.0055 | 0.5909 | <0.0001 |
rs2596548 | G/T | 0.2749 | 0.0268 | 0.2615 | 0.2138 | 0.3223 | 0.0751 | 0.9065 | 0.2475 | |
CCDC63 | rs10849915 | T/C | 0.3386 | 0.2256 | 0.2891 | 0.0025 | 0.0135 | 0.0060 | 0.5869 | <0.0001 |
Data are P-values. The association between genotypes of each SNP and intermediate phenotypes was examined with Pearson's χ2 test. Based on Bonferroni's correction, P<0.0003 (0.05/200) were considered statistically significant and are shown in bold. SNP, single nucleotide polymorphism; DM, diabetes mellitus; hyper-TG, hypertriglyceridemia; hypo-HDL, hypo-high density lipoprotein-cholesterolemia; hyper-LDL, hyper-low density lipoprotein-cholesterolemia; CKD, chronic kidney disease.